Key Details
Price
$181.00Last Dividend
$1.55Annual Revenue
$54.32 BAnnual EPS
$2.72Annual ROE
35.13%Beta
0.25Events Calendar
Next earnings date:
Jan 31, 2025Recent quarterly earnings:
Oct 30, 2024Recent annual earnings:
Feb 02, 2024Next ex-dividend date:
Jan 15, 2025Recent ex-dividend date:
Oct 15, 2024Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
This Analyst Blog features companies like Eli Lilly, Johnson & Johnson, AbbVie, AstraZeneca, and Pfizer.
NORTH CHICAGO, Ill., Jan. 3, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) is set to release its financial results for the entire year and the fourth quarter of 2024 on Friday, January 31, 2025, before the market opens.
In periods of market instability and uncertainty, many investors seek out stocks that pay dividends. These stocks usually belong to companies with strong cash flows that provide generous dividends to their shareholders.
This Analyst Blog features companies like Eli Lilly, Johnson & Johnson, AbbVie, AstraZeneca, and Pfizer.
AbbVie (ABBV) could see an increase in its stock price due to rising confidence in its earnings potential, as shown by its upgrade to a Zacks Rank #2 (Buy).
Lately, users of Zacks.com have been focusing on AbbVie (ABBV). Therefore, it's important to take a look at what this stock might offer.
In the past ten years, only 11 Dividend Kings have done better than the S&P 500 in terms of Total Return. According to my unique quantitative model, 5 of these Dividend Kings are considered "High Quality." By using a modified quality score, it could have resulted in a total return that was almost twice as much as the S&P 500 over the last 9 years.
If you're interested in stocks that pay good dividends, that's a wise choice. If you aren't considering them, you might want to think again, because:
In the most recent trading session, AbbVie (ABBV) finished at $180, which is an increase of 0.9% compared to the day before.
We have just released a list of the 10 Best Stocks to Buy and Hold for the Next 3 Years. In this article, we will examine how AbbVie Inc. (NYSE:ABBV) compares to the other top stocks on this list. What can we anticipate from the stock market in 2025?
FAQ
- What is the primary business of AbbVie?
- What is the ticker symbol for AbbVie?
- Does AbbVie pay dividends?
- What sector is AbbVie in?
- What industry is AbbVie in?
- What country is AbbVie based in?
- When did AbbVie go public?
- Is AbbVie in the S&P 500?
- Is AbbVie in the NASDAQ 100?
- Is AbbVie in the Dow Jones?
- When was AbbVie's last earnings report?
- When does AbbVie report earnings?
- Should I buy AbbVie stock now?